Grand Blanc, Mich. – McLaren Health Care system is proud to announce the launch of its full-scale digital pathology program, effective July 1, 2025. This breakthrough in diagnostic medicine transforms McLaren's speed, accuracy, and ability to detect and predict diseases across the 12-hospital system fully integrated health system.
“McLaren’s shift from traditional glass slides to digital pathology is more than a technological upgrade—it’s transformational for patient care,” said Ali Gabali, M.D., Ph.D., chief medical director of pathology and laboratory, and medical director of McLaren Corporate Laboratory. “We’re proud to be among the first in the region to implement digital pathology at this scale, and to lead the way in enhancing disease diagnosis.”
Beginning July 1, pathology services across the health system’s 12 hospital locations and central core laboratory will transition to high-resolution digital imaging. Traditional glass slides will be scanned into ultra-detailed high-resolution digital images that can be securely accessed remotely by pathologists across the health system, reviewed collaboratively, and integrated into electronic health records—streamlining diagnostics, accelerating care, and unlocking new opportunities for collaboration and precision. Digital pathology improves access to expert review, accelerates turnaround times, and enables the ability to leverage artificial intelligence and remote consultation, which eliminates delays caused by courier transport, and connects subspecialists regardless of location.
“Faster diagnoses and reduced turnaround time means earlier treatment decisions, faster peace of mind for patients, and ultimately greater outcomes,” said Dr. Gabali. “McLaren’s pathology, lab, IT, and operational teams have invested significantly in this cross-disciplinary collaboration to build a system that is as patient-centered as it is technically advanced.”
Digital pathology is emerging as a global standard in health care. By adopting this technology system-wide, McLaren Health Care joins a select group of leading health systems redefining diagnostics into the future.
About McLaren Health Care
McLaren Health Care, headquartered in Grand Blanc, Michigan, is a $7.3 billion, fully integrated health care delivery system committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 12 hospitals in Michigan, ambulatory surgery centers, imaging centers, a 640-member employed primary and specialty care physician network, commercial and Medicaid HMOs covering more than 732,838 lives in Michigan and Indiana, home health, infusion and hospice providers, pharmacy services, a clinical laboratory network and a wholly owned medical malpractice insurance company. McLaren operates Michigan’s largest network of cancer centers and providers, anchored by the Karmanos Cancer Institute, a National Cancer Institute-designated comprehensive cancer centers. McLaren has 20,000 full-, part-time and contracted employees and more than 113,000 network providers throughout Michigan, Indiana and Ohio.
As part of its Graduate Medical Education (GME) program, McLaren maintains academic affiliations with medical schools at Wayne State University, Michigan State University and Central Medical University. McLaren’s seven (7) GME campuses offer 27 residencies and eight (8) fellowship programs that train over 650 future physicians annually. All GME programs at McLaren are overseen and managed centrally by the Department of Academic Affairs.
More information is available at www.mclaren.org.